| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.23M | 15.81M | 15.48M | 22.33M | 22.09M | 23.41M |
| Gross Profit | 5.05M | 4.96M | 4.33M | 5.92M | 5.52M | 7.10M |
| EBITDA | 711.00K | 1.02M | -1.51M | 694.00K | -62.00K | 2.00M |
| Net Income | -37.00K | 280.00K | -3.70M | -686.00K | -436.00K | 1.03M |
Balance Sheet | ||||||
| Total Assets | 13.86M | 14.18M | 14.28M | 19.36M | 21.61M | 21.97M |
| Cash, Cash Equivalents and Short-Term Investments | 3.08M | 3.52M | 2.28M | 2.24M | 1.73M | 4.79M |
| Total Debt | 505.00K | 425.00K | 479.00K | 632.00K | 610.00K | 595.00K |
| Total Liabilities | 3.21M | 3.09M | 3.38M | 4.60M | 5.66M | 5.15M |
| Stockholders Equity | 10.66M | 11.09M | 10.94M | 14.70M | 15.65M | 16.41M |
Cash Flow | ||||||
| Free Cash Flow | 567.00K | 899.00K | 289.00K | 719.00K | -2.48M | 215.00K |
| Operating Cash Flow | 795.00K | 1.12M | 602.00K | 1.15M | -1.80M | 1.13M |
| Investing Cash Flow | -346.00K | 308.00K | -278.00K | -285.00K | -630.00K | -889.00K |
| Financing Cash Flow | -209.00K | -194.00K | -241.00K | -377.00K | -684.00K | -945.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £8.24M | 7.21 | 8.12% | 3.84% | -0.57% | 32.71% | |
73 Outperform | £1.19B | 23.41 | 18.46% | 1.68% | 26.72% | 29.51% | |
66 Neutral | £85.86M | 11.49 | 18.04% | 4.63% | -3.47% | -21.11% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | £636.52M | 13.92 | 6.89% | 3.19% | 7.27% | 34.79% | |
58 Neutral | £9.00M | -243.22 | -11.61% | ― | 15.82% | 98.85% | |
58 Neutral | £107.91M | 11.39 | 9.23% | 3.97% | 12.74% | -3.35% |